Literature DB >> 27992415

A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.

Ryan J Park1,2,3, Tim Wang3,4,5,6, Dylan Koundakjian1, Judd F Hultquist7,8, Pedro Lamothe-Molina1,9, Blandine Monel1,10, Kathrin Schumann11, Haiyan Yu3, Kevin M Krupzcak5, Wilfredo Garcia-Beltran1,2, Alicja Piechocka-Trocha1, Nevan J Krogan7,8, Alexander Marson11,12,13,14,15, David M Sabatini3,4,5,6,16, Eric S Lander3,4,17, Nir Hacohen3,18, Bruce D Walker1,3,10,19.   

Abstract

Host proteins are essential for HIV entry and replication and can be important nonviral therapeutic targets. Large-scale RNA interference (RNAi)-based screens have identified nearly a thousand candidate host factors, but there is little agreement among studies and few factors have been validated. Here we demonstrate that a genome-wide CRISPR-based screen identifies host factors in a physiologically relevant cell system. We identify five factors, including the HIV co-receptors CD4 and CCR5, that are required for HIV infection yet are dispensable for cellular proliferation and viability. Tyrosylprotein sulfotransferase 2 (TPST2) and solute carrier family 35 member B2 (SLC35B2) function in a common pathway to sulfate CCR5 on extracellular tyrosine residues, facilitating CCR5 recognition by the HIV envelope. Activated leukocyte cell adhesion molecule (ALCAM) mediates cell aggregation, which is required for cell-to-cell HIV transmission. We validated these pathways in primary human CD4+ T cells through Cas9-mediated knockout and antibody blockade. Our findings indicate that HIV infection and replication rely on a limited set of host-dispensable genes and suggest that these pathways can be studied for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27992415      PMCID: PMC5511375          DOI: 10.1038/ng.3741

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  75 in total

1.  ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation.

Authors:  Nicholas A Zumwalde; Eisuke Domae; Matthew F Mescher; Yoji Shimizu
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

2.  A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis.

Authors:  Kristoffer Weber; Udo Bartsch; Carol Stocking; Boris Fehse
Journal:  Mol Ther       Date:  2008-02-12       Impact factor: 11.454

3.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

Review 4.  Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases.

Authors:  Helena Yusuf-Makagiansar; Meagan E Anderson; Tatyana V Yakovleva; Joseph S Murray; Teruna J Siahaan
Journal:  Med Res Rev       Date:  2002-03       Impact factor: 12.944

5.  Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence.

Authors:  Christoph Seibert; Martine Cadene; Anthony Sanfiz; Brian T Chait; Thomas P Sakmar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

Review 6.  Legionella pneumophila type IV effectors hijack the transcription and translation machinery of the host cell.

Authors:  Monica Rolando; Carmen Buchrieser
Journal:  Trends Cell Biol       Date:  2014-07-08       Impact factor: 20.808

7.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

8.  AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.

Authors:  Matthew R Gardner; Lisa M Kattenhorn; Hema R Kondur; Markus von Schaewen; Tatyana Dorfman; Jessica J Chiang; Kevin G Haworth; Julie M Decker; Michael D Alpert; Charles C Bailey; Ernest S Neale; Christoph H Fellinger; Vinita R Joshi; Sebastian P Fuchs; Jose M Martinez-Navio; Brian D Quinlan; Annie Y Yao; Hugo Mouquet; Jason Gorman; Baoshan Zhang; Pascal Poignard; Michel C Nussenzweig; Dennis R Burton; Peter D Kwong; Michael Piatak; Jeffrey D Lifson; Guangping Gao; Ronald C Desrosiers; David T Evans; Beatrice H Hahn; Alexander Ploss; Paula M Cannon; Michael S Seaman; Michael Farzan
Journal:  Nature       Date:  2015-02-18       Impact factor: 49.962

9.  Clustering of dendritic cells, helper T lymphocytes, and histocompatible B cells during primary antibody responses in vitro.

Authors:  K Inaba; M D Witmer; R M Steinman
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

10.  LEDGF/p75 interacts with mRNA splicing factors and targets HIV-1 integration to highly spliced genes.

Authors:  Parmit Kumar Singh; Matthew R Plumb; Andrea L Ferris; James R Iben; Xiaolin Wu; Hind J Fadel; Brian T Luke; Caroline Esnault; Eric M Poeschla; Stephen H Hughes; Mamuka Kvaratskhelia; Henry L Levin
Journal:  Genes Dev       Date:  2015-11-01       Impact factor: 11.361

View more
  119 in total

1.  A Genome-Wide CRISPR-Cas9 Screen Reveals the Requirement of Host Cell Sulfation for Schmallenberg Virus Infection.

Authors:  Thiprampai Thamamongood; Andrea Aebischer; Valentina Wagner; Max W Chang; Roland Elling; Christopher Benner; Adolfo García-Sastre; Georg Kochs; Martin Beer; Martin Schwemmle
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Identification of Functionally Relevant microRNAs in the Regulation of Allergic Inflammation.

Authors:  Marlys S Fassett; Heather H Pua; Laura J Simpson; David F Steiner; K Mark Ansel
Journal:  Methods Mol Biol       Date:  2018

3.  MALTA: a calculator for estimating the coverage with shRNA, CRISPR, and cDNA libraries.

Authors:  Venkatramanan Krishnamani; Mark A Stamnes; Robert C Piper
Journal:  SoftwareX       Date:  2019-02-14

4.  New Connections: Cell-to-Cell HIV-1 Transmission, Resistance to Broadly Neutralizing Antibodies, and an Envelope Sorting Motif.

Authors:  S Abigail Smith; Cynthia A Derdeyn
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

5.  HIV: CRISPR screen identifies novel therapeutic targets.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2017-02-02       Impact factor: 84.694

Review 6.  New targets for HIV drug discovery.

Authors:  Ana C Puhl; Alfredo Garzino Demo; Vadim A Makarov; Sean Ekins
Journal:  Drug Discov Today       Date:  2019-03-15       Impact factor: 7.851

Review 7.  Elucidation of host-pathogen protein-protein interactions to uncover mechanisms of host cell rewiring.

Authors:  Charlotte Nicod; Amir Banaei-Esfahani; Ben C Collins
Journal:  Curr Opin Microbiol       Date:  2017-08-11       Impact factor: 7.934

Review 8.  A systems approach to infectious disease.

Authors:  Manon Eckhardt; Judd F Hultquist; Robyn M Kaake; Ruth Hüttenhain; Nevan J Krogan
Journal:  Nat Rev Genet       Date:  2020-02-14       Impact factor: 53.242

9.  Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9-Cas12a platform.

Authors:  Thomas Gonatopoulos-Pournatzis; Michael Aregger; Kevin R Brown; Shaghayegh Farhangmehr; Ulrich Braunschweig; Henry N Ward; Kevin C H Ha; Alexander Weiss; Maximilian Billmann; Tanja Durbic; Chad L Myers; Benjamin J Blencowe; Jason Moffat
Journal:  Nat Biotechnol       Date:  2020-03-16       Impact factor: 54.908

10.  Necroptosis-based CRISPR knockout screen reveals Neuropilin-1 as a critical host factor for early stages of murine cytomegalovirus infection.

Authors:  Rebecca K Lane; Hongyan Guo; Amanda D Fisher; Jonathan Diep; Zhao Lai; Yidong Chen; Jason W Upton; Jan Carette; Edward S Mocarski; William J Kaiser
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.